Jin Medical International Ltd (ZJYL)
Company Info
Highlights
$122.81M
$0.02
39.23
$12.95M
$5.81M
$2.53M
$0.56 - $4.38
0.76%
2.08
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Jin Medical International Ltd (ZJYL) returned 0.90% year-to-date (YTD) and -71.35% over the past 12 months.
ZJYL
0.90%
-12.39%
-17.11%
-71.35%
N/A
N/A
N/A
^GSPC (Benchmark)
-1.34%
5.02%
-3.08%
9.39%
13.76%
14.45%
10.68%
Monthly Returns
The table below presents the monthly returns of ZJYL, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 13.11% | -21.82% | 7.99% | 22.48% | -13.74% | 0.90% | |||||||
| 2024 | 6.53% | -52.47% | -38.85% | -0.78% | -28.08% | -5.11% | 7.69% | 7.50% | -10.63% | -25.65% | -54.50% | -14.51% | -93.73% |
| 2023 | -6.29% | 2.42% | -25.01% | 99.41% | 24.72% | -7.73% | 78.22% | -62.22% | 172.17% | 930.96% | 3,020.13% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of ZJYL is 20, meaning it’s performing worse than 80% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Jin Medical International Ltd (ZJYL) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Jin Medical International Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Jin Medical International Ltd was 95.79%, occurring on Apr 9, 2025. The portfolio has not yet recovered.
The current Jin Medical International Ltd drawdown is 94.31%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -95.79% | Jan 26, 2024 | 302 | Apr 9, 2025 | — | — | — |
| -69.42% | Jan 3, 2024 | 7 | Jan 11, 2024 | 9 | Jan 25, 2024 | 16 |
| -68.65% | Oct 5, 2023 | 19 | Oct 31, 2023 | 26 | Dec 7, 2023 | 45 |
| -44.06% | May 2, 2023 | 15 | May 22, 2023 | 14 | Jun 12, 2023 | 29 |
| -38.11% | Dec 20, 2023 | 2 | Dec 21, 2023 | 1 | Dec 22, 2023 | 3 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Jin Medical International Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Jin Medical International Ltd, comparing actual results with analytics estimates.
Valuation
The Valuation section provides an overview of how Jin Medical International Ltd is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for ZJYL, comparing it with other companies in the Medical Instruments & Supplies industry. Currently, ZJYL has a P/E ratio of 39.2. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ZJYL relative to other companies in the Medical Instruments & Supplies industry. Currently, ZJYL has a P/S ratio of 5.2. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for ZJYL in comparison with other companies in the Medical Instruments & Supplies industry. Currently, ZJYL has a P/B value of 4.3. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |